GlycoMimetics, Inc

(NASDAQ:GLYC)

Latest On GlycoMimetics, Inc (GLYC):

Date/Time Type Description Signal Details
2023-05-30 15:17 ESTNewsGlycoMimetics: Insider Buying Continues, And Chart Looks HealthyN/A
2023-05-10 16:14 ESTNewsGlycoMimetics: An Asymmetric Opportunity That Could Change HematologyN/A
2023-05-04 00:06 ESTNewsGlycoMimetics, Inc. (GLYC) Q1 2023 Earnings Call TranscriptN/A
2023-05-03 10:57 ESTNewsGlycoMimetics GAAP EPS of -$0.17 in-lineN/A
2023-04-04 15:04 ESTNewsGlycoMimetics Has Few Risks, Great Outlook In LeukemiaN/A
2023-03-29 13:01 ESTNewsGlycoMimetics GAAP EPS of -$0.19 misses by $0.02N/A
2023-03-29 13:00 ESTNewsGlycoMimetics, Inc. (GLYC) Q4 2022 Earnings Call TranscriptN/A
2023-03-13 13:57 ESTNewsRAPT Therapeutics, Repare Therapeutics among biotechs to disclose exposure to Silicon Valley BankN/A
2023-03-09 01:56 ESTNewsGlycoMimetics: Stock Price Drop Brings Great Speculative Trade OpportunityN/A
2023-02-22 13:21 ESTNewsGlycoMimetics slips as chief scientific officer departsN/A
2023-02-18 18:22 ESTNewsStocks To Watch: Retail Gets Tested With Walmart, Home Depot And CAGNY Conference On TapN/A
2023-02-17 16:57 ESTNewsGlycoMimetics: Unraveling The Tea LeavesN/A
2023-02-15 11:21 ESTNewsGlycoMimetics sheds 39% after 11.8M stock offeringN/A
2023-01-03 16:22 ESTNewsGlycoMimetics: A Cancer-Cure Lottery Ticket Grabbing My AttentionN/A
2022-11-12 05:25 ESTNewsGlycoMimetics Could Surge If Q1 Data Readout Is PositiveN/A
2022-11-10 00:37 ESTNewsGlycoMimetics GAAP EPS of -$0.16 beats by $0.10N/A
2022-11-10 00:36 ESTNewsGlycoMimetics, Inc. (GLYC) Q3 2022 Earnings Call TranscriptN/A
2022-09-06 09:09 ESTNewsGlycoMimetics has a new Chief Medical OfficerN/A
2022-08-03 21:08 ESTNewsGlycoMimetics GAAP EPS of $0.25 beats by $0.53, revenue of $75KN/A
2022-08-03 21:07 ESTNewsGlycoMimetics, Inc. (GLYC) CEO Harout Semerjian on Q2 2022 Results - Earnings Call TranscriptN/A
2022-04-30 17:59 ESTNewsGlycoMimetics, Inc. (GLYC) CEO Harout Semerjian on Q1 2022 Results - Earnings Call TranscriptN/A
2022-04-28 13:35 ESTNewsGlycoMimetics GAAP EPS of -$0.28 beats by $0.03N/A
2022-04-27 22:51 ESTNewsGlycoMimetics Q1 2022 Earnings PreviewN/A
2022-03-17 10:10 ESTNewsGlycoMimetics Positive Data For AML Therapy Increasingly LikelyN/A
2022-03-17 10:09 ESTNewsGlycoMimetics' Uproleselan: Secondary Reasons To Own The StockN/A
2022-03-04 23:25 ESTNewsGlycoMimetics files for $250M mixed shelf offeringN/A
2022-03-03 12:03 ESTNewsGlycoMimetics GAAP EPS of -$0.33 beats by $0.01, revenue of $0.18MN/A
2022-03-03 12:02 ESTNewsGlycoMimetics, Inc. (GLYC) CEO Harout Semerjian on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-02 17:47 ESTNewsGlycoMimetics Q4 2021 Earnings PreviewN/A
2021-11-12 21:45 ESTNewsGlycoMimetics A Buy On Nearing Trial Enrollment CompletionN/A
2021-11-02 16:41 ESTNewsGlycoMimetics reports Q3 resultsN/A
2021-11-02 16:40 ESTNewsGlycoMimetics, Inc. (GLYC) CEO Harout Semerjian on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-01 20:02 ESTNewsGlycoMimetics Q3 2021 Earnings PreviewN/A
2021-09-26 20:14 ESTNewsGlycoMimetics (GLYC) Investor Presentation - SlideshowN/A
2021-09-24 05:04 ESTNewsGlycoMimetics shares jump 12% after highlighting promising data from uproleselan leukemia trialN/A
2021-08-08 12:49 ESTNewsGlycoMimetics, Inc. (GLYC) CEO Rachel King on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-06 03:42 ESTNewsGlycoMimetics EPS beats by $0.03N/A
2021-08-05 05:21 ESTNewsGlycoMimetics names Harout Semerjian as chief executive officerN/A
2021-07-23 00:09 ESTNewsTreatment gets underway in early-stage leukemia trial of GlycoMimetics' uproleselanN/A
2021-07-21 10:27 ESTNewsGlycoMimetics says first patient dosed in investigator-sponsored mid-stage uproleselan studyN/A
2021-07-21 09:54 ESTNewsDosing gets underway in GlycoMimetics' uproleselan combination leukemia studyN/A
2021-05-03 23:14 ESTNewsGlycoMimetics, Inc. (GLYC) CEO Rachel King on Q1 2021 Results - Earnings Call TranscriptN/A
2021-03-04 11:44 ESTAnalyst RatingThe Analyst Target Price has decreased from $10.5 to $10.25.Neutral
2021-03-04 07:43 ESTFinancialsCompany financials have been released.Neutral
2021-03-03 11:42 ESTEarnings EstimateAn EPS average of -$1.36 is estimated for the 2022 year.Sell
2021-03-03 11:42 ESTEarnings EstimateAn EPS average of -$0.31 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-03 07:24 ESTNewsGlycoMimetics, Inc.'s (GLYC) CEO Rachel King on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-02 13:01 ESTNewsGlycoMimetics EPS in-line, misses on revenueN/A
2021-02-23 14:50 ESTNewsGlycoMimetics picks internal candidate for chief medical officerN/A
2020-12-08 11:54 ESTAnalyst RatingThe Analyst Target Price has increased from $9 to $10.5.Buy

About GlycoMimetics, Inc (GLYC):

GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. The company's drug candidate include rivipansel, a pan-selectin antagonist for the treatment of vaso-occlusive crisis in sickle cell disease. It is also developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as Phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing GMI-1359 to target E-selectin and a chemokine receptors. It also develops various other programs, including GMI-1687, an antagonist of E-selectin; and Galectin-3, a carbohydrate-binding protein. The company has a cooperative research and development agreement with the National Cancer Institute; and collaboration and license agreement with Apollomics for the development and commercialization of uproleselan and GMI-1687. GlycoMimetics, Inc. was founded in 2003 and is headquartered in Rockville, Maryland.

GLYC Quotes by TradingView

See Advanced Chart

General

  • Name GlycoMimetics, Inc
  • Symbol GLYC
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 54
  • Fiscal Year EndDecember
  • IPO Date2014-01-10
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://glycomimetics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 15.03
  • Price/Book (Most Recent Quarter) 1.34
  • Enterprise Value Revenue 3.72
  • Enterprise Value EBITDA 0.09
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.28
  • Next Year EPS Estimate -$1.40
  • Next Quarter EPS Estimate -$0.33
  • Operating Margin -507%
  • Return on Assets -21%
  • Return on Equity -36%
  • Revenue 10.16 million
  • Earnings Per Share -$1.28
  • Revenue Per Share $0.22
  • Gross Profit 10.16 million
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 177.14 million
  • EBITDA -59150020
  • Analyst Target Price $10.25
  • Book Value Per Share $2.62
View More

Share Statistics

  • Shares Outstanding 51.49 million
  • Shares Float 31.78 million
  • % Held by Insiders 215%
  • % Held by Institutions 78.59%
  • Shares Short 1.07 million
  • Shares Short Prior Month 919111
  • Short Ratio 1.15
  • Short % of Float 4%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 2.4
  • 52 Week High $5.19
  • 52 Week Low $1.94
  • 50 Day Moving Average 3.61
  • 200 Day Moving Average 3.56
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

GlycoMimetics, Inc (GLYC) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

GlycoMimetics, Inc (GLYC) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-02$163000-$0.32-$0.320.62%
2020-09-302020-11-06$N/A-$0.29-$0.328.43%
2020-06-302020-07-31$N/A-$0.32-$0.3713.51%
2020-03-312020-05-01$N/A-$0.18-$0.2937.93%
2019-12-312020-02-28$N/A-$0.34-$0.353.41%
2019-09-302019-11-07$N/A-$0.31-$0.4123.46%
2019-06-302019-08-01$N/A-$0.37-$0.370%
2019-03-312019-05-02$N/A-$0.33-$0.367.3%
2018-12-312019-03-06$N/A-$0.32-$0.31-3.9%
2018-09-302018-11-02$N/A-$0.27-$0.3216.49%
2018-06-302018-08-09$N/A-$0.26-$0.3422.96%
2018-03-312018-05-03$N/A-$0.33-$0.28-17.86%
2017-12-312018-03-06$N/A-$0.27-$0.25-8.87%
2017-09-302017-11-08$N/A-$0.24-$0.3018.64%
2017-06-302017-08-03$N/A-$0.30-$0.3514.29%
2017-03-312017-05-08$N/A-$0.34-$0.365.56%
2016-12-312017-03-01$-500-$0.36-$0.360%
2016-09-302016-11-04$19000-$0.34-$0.4218.07%
2016-06-302016-08-04$N/A-$0.41-$0.4814.58%
2016-03-312016-05-04$N/A-$0.40-$0.4613.04%
2015-12-312016-02-29$36000-$0.47-$0.470%
2015-09-302015-11-12$-20035000-$0.38-$0.405%
2015-06-302015-08-06$20.04 million$0.51-$0.40227.5%
2015-03-312015-05-05$N/A-$0.37-$0.370%
2014-12-312015-03-16$15.03 million-$0.39-$0.22-77.27%
2014-09-302014-10-31$-15027000-$0.35$0.21-266.67%
2014-06-302014-07-31$15.03 million$0.39$0.2462.5%
2014-03-312014-05-09$23.59 million-$0.30-$0.300%

GlycoMimetics, Inc (GLYC) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development 11.72 million 10.67 million N/A N/A 11.47 million
Income Before Tax -15.56 million -13.72 million N/A N/A -14.73 million
Selling General Administrative 4.01 million 4.06 million N/A N/A 3.87 million
Gross Profit N/A N/A N/A N/A N/A
Ebit -15.57 million -13.73 million N/A N/A -15.34 million
Operating Income -15.57 million -13.73 million N/A N/A -15.34 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue 163000 N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A N/A N/A N/A 608792
Net Income From Continuing Operations -15.56 million -13.72 million N/A N/A -14.73 million
Net Income Applicable to Common Shares -15.56 million -13.72 million -14.08 million -7.66 million -14.73 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A N/A N/A N/A
Change to Liabilities 89000 -1.77 million 1.7 million 28112 -1.62 million
Total Cash Flow from Investing Activities -15813 -6383 -8136 -12357 -18266
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities 4.55 million N/A N/A 119822 186770
Change to Operating Activities N/A -700824 409242 -49028 -391408
Change in Cash -6.97 million N/A N/A -12.69 million -13.28 million
Total Cash from Operating Activities -11.5 million -14.55 million -3.5 million -12.79 million -13.45 million
Depreciation 66527 N/A N/A 67843 -233083
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income 1.69 million 1.76 million 1.82 million 1.89 million 2.05 million
Capital Expenditures 15813 N/A N/A 12357 18266
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities 14.61 million 12.15 million N/A N/A 13.77 million
Total Stockholder Equity 128.22 million 138.27 million N/A N/A 154.2 million
Other Current Liabilities 898549 874158 N/A N/A N/A
Total Assets 142.83 million 150.42 million N/A N/A 167.97 million
Common Stock 49018 47829 N/A 43581 43465
Other Current Assets 1.24 million 2.77 million N/A N/A N/A
Retained Earnings -309.47 million -293.91 million N/A -266.11 million -258.44 million
Other Liabilities 264329 N/A N/A 393273 N/A
Other Assets 1.61 million N/A N/A 1.61 million 1.61 million
Cash 137.04 million 142.87 million N/A N/A 158.2 million
Total Current Liabilities 12.43 million 9.82 million N/A N/A 10.95 million
Other Stockholder Equity N/A N/A N/A N/A N/A
Property, Plant & Equipment 620673 661541 N/A 3.6 million 3.83 million
Total Current Assets 138.27 million 145.64 million N/A N/A 162.53 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 128.22 million 138.27 million 148.49 million 148.49 million 154.2 million
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 11.53 million 8.94 million N/A N/A 1.44 million

GlycoMimetics, Inc (GLYC) Chart:

GlycoMimetics, Inc (GLYC) News:

Below you will find a list of latest news for GlycoMimetics, Inc (GLYC) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

GlycoMimetics, Inc (GLYC) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-1711.15CALL0 32368.78TRUE00
2024-05-172.50.3CALL475 2686403.69FALSE00
2024-05-1740.2CALL20 2075452.96FALSE0.20
2024-05-1750.11CALL29 292420.65FALSE-0.08-0.42
2024-05-1760.45CALL0 580FALSE00
2024-05-177.50.05CALL211 10968423.74FALSE-0.04-0.44
2024-05-1710.2PUT364 8960400.85FALSE00
2024-05-172.51.3PUT87 11582445.16TRUE0.050.04
2024-05-1742.4PUT0 485438.08TRUE00
2024-05-1753.3PUT0 12783.22TRUE00
2024-05-1760PUT0 0555TRUE00
2024-05-177.55.55PUT0 20646.51TRUE00
2024-06-2111CALL0 510TRUE00
2024-06-212.50.7CALL48 2611406.93FALSE0.050.08
2024-06-2140.5CALL0 1340FALSE00
2024-06-2150.43CALL33 3678391.46FALSE0.050.13
2024-06-2160.8CALL0 360FALSE00
2024-06-217.50.23CALL27 5654353.29FALSE-0.05-0.18
2024-06-2110.35PUT124 2338331.99FALSE0.050.17
2024-06-212.51.5PUT32 2669345.22TRUE-0.1-0.06
2024-06-2142.9PUT179 6033378.94TRUE2.90
2024-06-2153.4PUT0 44412.13TRUE00
2024-06-2160PUT0 0438.1TRUE00
2024-06-217.50PUT0 0872.3TRUE00
2024-07-1911.26CALL0 330TRUE00
2024-07-1920CALL0 00FALSE00
2024-07-192.50.8CALL0 2394271.98FALSE00
2024-07-1930CALL0 00FALSE00
2024-07-1940.5CALL0 25070FALSE00
2024-07-1951.77CALL310 300FALSE1.770
2024-07-1960.9CALL0 15324.12FALSE00
2024-07-197.51.57CALL310 650FALSE1.570
2024-07-1910.45PUT0 860FALSE00
2024-07-1920PUT0 00TRUE00
2024-07-192.51.51PUT10 51284.35TRUE1.510
2024-07-1930PUT0 00TRUE00
2024-07-1940PUT0 0201.01TRUE00
2024-07-1953.2PUT0 1371.63TRUE00
2024-07-1960PUT0 0358.32TRUE00
2024-07-197.50PUT0 0492.2TRUE00
2024-09-2011.62CALL0 2424.16TRUE00
2024-09-202.50.9CALL40 196305.76FALSE0.90
2024-09-2040.66CALL0 11782240.69FALSE00
2024-09-2050.5CALL20 4597253.05FALSE0.50
2024-09-2060.52CALL0 18235.17FALSE00
2024-09-207.50.46CALL0 2713238.69FALSE00
2024-09-2010.47PUT0 195258.43FALSE00
2024-09-202.51.65PUT0 3001234.61TRUE00
2024-09-2042.96PUT0 11236.95TRUE00
2024-09-2053.2PUT0 0312.31TRUE00
2024-09-2060PUT0 0460.75TRUE00
2024-09-207.56.1PUT0 1296.8TRUE00
2024-12-2010CALL0 00TRUE00
2024-12-2020CALL0 00FALSE00
2024-12-202.50CALL0 00FALSE00
2024-12-2051.47CALL1 0541.96FALSE1.470
2024-12-207.52.65CALL0 120FALSE00
2024-12-2010PUT0 00FALSE00
2024-12-2020PUT0 00TRUE00
2024-12-202.50PUT0 0204.88TRUE00
2024-12-2050PUT0 0230.38TRUE00
2024-12-207.50PUT0 0285.05TRUE00

Latest GLYC Trades:

Date Shares Price
Jun 13, 2022 5:30 PM EST100$0.6216
Jun 13, 2022 6:41 PM EST85$0.6287
Jun 13, 2022 7:01 PM EST100$0.6216
Jun 13, 2022 7:58 PM EST100$0.6066
Jun 13, 2022 7:58 PM EST100$0.6066

GlycoMimetics, Inc (GLYC) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120032315/0001209191-20-032315-index.htm
2019-05-23UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1253689/000000000019008876/0000000000-19-008876-index.htm
2019-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000003877719000032/0000038777-19-000032-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000008025519002657/0000080255-19-002657-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000008025520001261/0000080255-20-001261-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000021545719006611/0000215457-19-006611-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000031506619001057/0000315066-19-001057-index.htm
2019-08-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000031506619001676/0000315066-19-001676-index.htm
2019-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000031506619001702/0000315066-19-001702-index.htm
2018-09-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000072888918001483/0000728889-18-001483-index.htm
2019-01-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000072888919000038/0000728889-19-000038-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000083423720005369/0000834237-20-005369-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000090221919000165/0000902219-19-000165-index.htm
2020-01-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000090221920000035/0000902219-20-000035-index.htm
2020-04-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000090221920000372/0000902219-20-000372-index.htm
2019-06-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000091420819000279/0000914208-19-000279-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000091420820000058/0000914208-20-000058-index.htm
2020-04-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000091420820000283/0000914208-20-000283-index.htm
2020-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000091420820000361/0000914208-20-000361-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000092189518000663/0000921895-18-000663-index.htm
2019-08-15SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000092189519002247/0000921895-19-002247-index.htm
2019-08-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000092189519002332/0000921895-19-002332-index.htm
2019-09-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000092189519002380/0000921895-19-002380-index.htm
2019-09-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000092189519002381/0000921895-19-002381-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000092189520000539/0000921895-20-000539-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000092189520002779/0000921895-20-002779-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000092189520002828/0000921895-20-002828-index.htm
2020-07-20SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000093583620000390/0000935836-20-000390-index.htm
2018-03-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1253689/000104746918001847/0001047469-18-001847-index.htm
2018-03-21424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1253689/000104746918001954/0001047469-18-001954-index.htm
2019-05-17S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1253689/000104746919003186/0001047469-19-003186-index.htm
2020-10-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1253689/000104746920005139/0001047469-20-005139-index.htm
2018-03-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000110465918019322/0001104659-18-019322-index.htm
2019-05-23CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1253689/000110465919031465/0001104659-19-031465-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000114420419008076/0001144204-19-008076-index.htm
2018-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118009860/0001209191-18-009860-index.htm
2018-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118029614/0001209191-18-029614-index.htm
2018-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118029615/0001209191-18-029615-index.htm
2018-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118029616/0001209191-18-029616-index.htm
2018-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118029619/0001209191-18-029619-index.htm
2018-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118031812/0001209191-18-031812-index.htm
2018-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118031817/0001209191-18-031817-index.htm
2018-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118031825/0001209191-18-031825-index.htm
2018-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118031836/0001209191-18-031836-index.htm
2018-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118031842/0001209191-18-031842-index.htm
2018-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118031858/0001209191-18-031858-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118033068/0001209191-18-033068-index.htm
2018-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118037288/0001209191-18-037288-index.htm
2018-10-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118055586/0001209191-18-055586-index.htm
2018-11-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118060156/0001209191-18-060156-index.htm
2018-11-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919118060160/0001209191-18-060160-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119004821/0001209191-19-004821-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119004823/0001209191-19-004823-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119004825/0001209191-19-004825-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119004827/0001209191-19-004827-index.htm
2019-03-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119017473/0001209191-19-017473-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119031714/0001209191-19-031714-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119031716/0001209191-19-031716-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119031718/0001209191-19-031718-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119031720/0001209191-19-031720-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119031725/0001209191-19-031725-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119031734/0001209191-19-031734-index.htm
2019-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119044967/0001209191-19-044967-index.htm
2019-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119046095/0001209191-19-046095-index.htm
2019-12-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919119061782/0001209191-19-061782-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120002098/0001209191-20-002098-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120004814/0001209191-20-004814-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120004818/0001209191-20-004818-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120004824/0001209191-20-004824-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120004826/0001209191-20-004826-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120004828/0001209191-20-004828-index.htm
2020-03-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120017836/0001209191-20-017836-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120032299/0001209191-20-032299-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120032302/0001209191-20-032302-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120032304/0001209191-20-032304-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120032308/0001209191-20-032308-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120032311/0001209191-20-032311-index.htm
2020-05-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1253689/000120919120032315/0001209191-20-032315-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000142573818000010/0001425738-18-000010-index.htm
2018-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837018001530/0001558370-18-001530-index.htm
2018-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1253689/000155837018001553/0001558370-18-001553-index.htm
2018-03-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1253689/000155837018001557/0001558370-18-001557-index.htm
2018-04-13DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1253689/000155837018002958/0001558370-18-002958-index.htm
2018-05-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837018003834/0001558370-18-003834-index.htm
2018-05-0310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1253689/000155837018003836/0001558370-18-003836-index.htm
2018-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837018004900/0001558370-18-004900-index.htm
2018-07-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837018005686/0001558370-18-005686-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1253689/000155837018006888/0001558370-18-006888-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837018006892/0001558370-18-006892-index.htm
2018-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837018008313/0001558370-18-008313-index.htm
2018-11-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1253689/000155837018008314/0001558370-18-008314-index.htm
2018-11-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837018009486/0001558370-18-009486-index.htm
2019-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837019001513/0001558370-19-001513-index.htm
2019-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1253689/000155837019001537/0001558370-19-001537-index.htm
2019-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837019001547/0001558370-19-001547-index.htm
2019-03-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1253689/000155837019001578/0001558370-19-001578-index.htm
2019-04-10DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1253689/000155837019002905/0001558370-19-002905-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837019003802/0001558370-19-003802-index.htm
2019-05-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1253689/000155837019003803/0001558370-19-003803-index.htm
2019-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837019005190/0001558370-19-005190-index.htm
2019-08-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1253689/000155837019006741/0001558370-19-006741-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837019006743/0001558370-19-006743-index.htm
2019-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837019007085/0001558370-19-007085-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1253689/000155837019010290/0001558370-19-010290-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837019010292/0001558370-19-010292-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837019011165/0001558370-19-011165-index.htm
2020-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837020000060/0001558370-20-000060-index.htm
2020-02-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837020000636/0001558370-20-000636-index.htm
2020-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1253689/000155837020001723/0001558370-20-001723-index.htm
2020-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837020001731/0001558370-20-001731-index.htm
2020-02-28S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1253689/000155837020001772/0001558370-20-001772-index.htm
2020-04-16DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1253689/000155837020003935/0001558370-20-003935-index.htm
2020-05-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1253689/000155837020004879/0001558370-20-004879-index.htm
2020-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837020004881/0001558370-20-004881-index.htm
2020-05-08DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1253689/000155837020005890/0001558370-20-005890-index.htm
2020-05-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837020006971/0001558370-20-006971-index.htm
2020-07-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1253689/000155837020008841/0001558370-20-008841-index.htm
2020-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837020008848/0001558370-20-008848-index.htm
2020-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837020011405/0001558370-20-011405-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1253689/000155837020013021/0001558370-20-013021-index.htm
2020-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1253689/000155837020013033/0001558370-20-013033-index.htm
2019-08-15SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1253689/000165495419009665/0001654954-19-009665-index.htm
2019-05-28EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1253689/999999999519001225/9999999995-19-001225-index.htm

GlycoMimetics, Inc (GLYC) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of GlycoMimetics, Inc (GLYC). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 215%
Institutional Ownership: 7859%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-06-11Brian M. HahnCFOSell19,345.0018.04348,983.800.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118037288/0001209191-18-037288-index.htm
2018-05-23John L. MagnaniSVP of Research, CSOBuy1,491.000.33492.03100,793.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118033068/0001209191-18-033068-index.htm
2019-08-13DANIEL M JUNIUSDirectorBuy10,000.003.1831,800.0018,000.00https://www.sec.gov/Archives/edgar/data/1253689/000120919119046095/0001209191-19-046095-index.htm
2019-12-20John L. MagnaniSVP of Research, CSOBuy106,984.001.12119,822.08182,777.00https://www.sec.gov/Archives/edgar/data/1253689/000120919119061782/0001209191-19-061782-index.htm
2018-06-11Brian M. HahnCFOBuy5,260.001.125,891.2019,345.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118037288/0001209191-18-037288-index.htm
2020-01-06John L. MagnaniSVP of Research, CSOBuy106,983.001.12119,820.96289,760.00https://www.sec.gov/Archives/edgar/data/1253689/000120919120002098/0001209191-20-002098-index.htm
2019-09-05PARTNERS L P/IL BVF10% Share HolderBuy689,834.003.182,195,051.792,955,440.00https://www.sec.gov/Archives/edgar/data/1253689/000092189519002381/0000921895-19-002381-index.htm
2019-08-06Rachel K. KingPresident, CEOBuy166,759.001.12186,770.08307,144.00https://www.sec.gov/Archives/edgar/data/1253689/000120919119044967/0001209191-19-044967-index.htm
2020-10-30PARTNERS L P/IL BVF10% Share HolderBuy250,755.002.75689,576.253,206,195.00https://www.sec.gov/Archives/edgar/data/1253689/000092189520002779/0000921895-20-002779-index.htm
2019-09-05PARTNERS L P/IL BVF10% Share HolderBuy853,956.003.182,717,287.993,639,935.00https://www.sec.gov/Archives/edgar/data/1253689/000092189519002381/0000921895-19-002381-index.htm
2020-11-04PARTNERS L P/IL BVF10% Share HolderBuy506,155.002.601,316,003.003,712,350.00https://www.sec.gov/Archives/edgar/data/1253689/000092189520002828/0000921895-20-002828-index.htm
2020-03-09DANIEL M JUNIUSDirectorBuy20,000.003.4068,000.0038,000.00https://www.sec.gov/Archives/edgar/data/1253689/000120919120017836/0001209191-20-017836-index.htm
2020-10-30PARTNERS L P/IL BVF10% Share HolderBuy666,385.002.751,832,558.754,306,320.00https://www.sec.gov/Archives/edgar/data/1253689/000092189520002779/0000921895-20-002779-index.htm
2018-05-10ENTERPRISE ASSOCIATES 10 L P NEW10% Share HolderSell4,006.0017.8171,346.864,702,791.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118029614/0001209191-18-029614-index.htm
2018-05-10M JAMES BARRETTDirectorSell4,006.0017.8171,346.864,702,791.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118029615/0001209191-18-029615-index.htm
2018-05-10PETER J BARRIS10% Share HolderSell4,006.0017.8171,346.864,702,791.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118029616/0001209191-18-029616-index.htm
2018-05-10SCOTT D SANDELL10% Share HolderSell4,006.0017.8171,346.864,702,791.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118029619/0001209191-18-029619-index.htm
2020-11-04PARTNERS L P/IL BVF10% Share HolderBuy674,492.002.601,753,679.204,980,812.00https://www.sec.gov/Archives/edgar/data/1253689/000092189520002828/0000921895-20-002828-index.htm
2018-05-10ENTERPRISE ASSOCIATES 10 L P NEW10% Share HolderSell5,533.0017.8198,542.734,995,664.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118029614/0001209191-18-029614-index.htm
2018-05-10M JAMES BARRETTDirectorSell5,533.0017.8198,542.734,995,664.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118029615/0001209191-18-029615-index.htm
2018-05-10PETER J BARRIS10% Share HolderSell5,533.0017.8198,542.734,995,664.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118029616/0001209191-18-029616-index.htm
2018-05-10SCOTT D SANDELL10% Share HolderSell5,533.0017.8198,542.734,995,664.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118029619/0001209191-18-029619-index.htm
2019-09-05PARTNERS L P/IL BVF10% Share HolderBuy124,956.003.18397,609.99528,891.00https://www.sec.gov/Archives/edgar/data/1253689/000092189519002381/0000921895-19-002381-index.htm
2020-10-30PARTNERS L P/IL BVF10% Share HolderBuy15,472.002.7542,548.00544,363.00https://www.sec.gov/Archives/edgar/data/1253689/000092189520002779/0000921895-20-002779-index.htm
2020-11-04PARTNERS L P/IL BVF10% Share HolderBuy86,090.002.60223,834.00630,453.00https://www.sec.gov/Archives/edgar/data/1253689/000092189520002828/0000921895-20-002828-index.htm
2018-10-18John L. MagnaniSVP of Research, CSOSell3,527.0014.0249,448.5475,793.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118055586/0001209191-18-055586-index.htm
2018-10-17John L. MagnaniSVP of Research, CSOSell7,273.0014.00101,822.0079,320.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118055586/0001209191-18-055586-index.htm
2018-10-16John L. MagnaniSVP of Research, CSOSell14,200.0014.01198,942.0086,593.00https://www.sec.gov/Archives/edgar/data/1253689/000120919118055586/0001209191-18-055586-index.htm